SCHEDULE 13G/A: BlackRock Amends Medtronic plc Stake, Disclosing 6.9% Beneficial Ownership
Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 6.9% of Medtronic plc's common stock as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 88,655,585 shares of Medtronic plc common stock.
- This represents 6.9% of Medtronic plc's outstanding common stock.
- BlackRock holds sole voting power over 79,708,326 shares.
- BlackRock holds sole dispositive power over 88,655,585 shares.
- The filing is an Amendment No. 8 to the Schedule 13G.
- The event date requiring this filing was March 31, 2025.
- BlackRock, Inc. is a Delaware corporation with its principal business office at 50 Hudson Yards, New York, NY 10001.
- Medtronic plc's principal executive offices are located in Galway, Ireland.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, providing no positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- The disclosure of a significant institutional stake by BlackRock, a major global asset manager, may signal confidence in Medtronic plc's long-term prospects.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities, and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Industry Context
This filing reflects a routine disclosure of a significant passive investment by a major asset manager in a leading medical technology company. It does not provide specific insights into Medtronic plc's operational performance or broader industry trends beyond confirming continued institutional interest.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by BlackRock provides transparency regarding the ownership structure of Medtronic plc, which can influence investor perception and market stability.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of previous Power of Attorney revoked by the new one. |
| 2025-01-21 | Date of execution for the new Power of Attorney. |
| 2025-03-31 | Date of event which required the filing of this statement. |
| 2025-04-23 | Date of filing of this Schedule 13G Amendment No. 8. |
Keywords
Medtronic plc, BlackRock Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.